No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

THINK Surgical Prepares for Full Commercial Launch of The TSolution One® Total Knee Application: To Be Available to Hospitals & Ambulatory Surgery Centers in the US Early 2021

Editor: What To Know

  • , vice chair, Orthopedic Surgery at Hackensack University Medical Center, which was the first hospital in the country to use the FDA cleared TSolution One Total Knee Application earlier this year.
  •  “As with the initial TSolution One Total Knee Application, the enhanced system provides submillimeter dimensional accuracy cuts optimizing the marriage of the implant to the bone.
  • The TSolution One Total Knee Application system is comprised of TPLAN®, the 3D pre-surgical planning workstation, and TCAT®, the active robot that helps the surgeon execute each patient’s individual preoperative plan with consistent results.

December 16, 2020

THINK Surgical advises their new system will be available to hospitals and ambulatory surgery centers in the United States in early 2021 following recent clearance by the Food and Drug Administration (FDA).

THINK Surgical is also preparing to upgrade systems currently in use throughout the United States. THINK’s TSolution One® Total Knee Application performs fully automated preparation of the bone and joint surface and supports an open platform enabling a choice of implants by surgeons.

“The new system has even more flexibility in preoperative planning and improved intraoperative efficiency in the set-up time,” said Stefan Kreuzer, M.D., founder of INOV8 Orthopedics in Houston, Texas, who has participated in validation labs, including clinical evaluation, of the second-generation system.  INOV8 Surgical was the first ambulatory surgery center in the United States to receive the first-generation TSolution One Total Knee Application earlier this year.  “As with the initial TSolution One Total Knee Application, the enhanced system provides submillimeter dimensional accuracy cuts optimizing the marriage of the implant to the bone.  I am looking forward to utilizing the new system to further improve patient care.”

The second-generation system incorporates several enhancements to the hardware and software including streamlined preoperative diagnostics; the addition of audio feedback to improve positional guidance during surgery; recovery marker detection to alert the surgeon if recovery markers are within the cut path; upgraded registration and cutting visualization; registration enhancements to reduce the time for bone registration; and a redesigned cutter drive assembly.

In addition, the new robot features LED lights to indicate various stages in the procedure.

“The new system will streamline the registration process to increase efficiency in the operating room, getting patients through the procedure faster,” said Yair D. Kissin, M.D., vice chair, Orthopedic Surgery at Hackensack University Medical Center, which was the first hospital in the country to use the FDA cleared TSolution One Total Knee Application earlier this year. “I am excited to use the new system to advance our total joint replacement surgery program.”

THINK Surgical received FDA 510(k) clearance of the second-generation active robot on November 13, 2020, approximately one year after the first-generation system was cleared.  As the new year approaches, THINK looks forward to engaging with new customers and demonstrating its unique and innovative technology for total knee replacement procedures.

“Receiving FDA clearance on our second-generation system demonstrates our team’s dedication to the continuous improvement of our active robot technology,” said Jay Yang, acting CEO, THINK Surgical. “The TSolution One Total Knee Application aims to improve patient satisfaction and expand the reproducibility of favorable outcomes in hospitals and ambulatory surgery centers. We are excited to introduce our technology to more orthopedic surgeons, helping them to improve the lives of patients who suffer from severe osteoarthritis.”

The TSolution One Total Knee Application system is comprised of TPLAN®, the 3D pre-surgical planning workstation, and TCAT®, the active robot that helps the surgeon execute each patient’s individual preoperative plan with consistent results.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy